Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia

Na Li,Peng An,Jifeng Wang,Tingting Zhang,Xiaoqing Qing,Bowen Wu,Lang Sun,Xiang Ding,Lili Niu,Zhensheng Xie,Mengmeng Zhang,Xiaojing Guo,Xiulan Chen,Tanxi Cai,Jianming Luo,Fudi Wang,Fuquan Yang
DOI: https://doi.org/10.1016/j.isci.2022.104091
IF: 5.8
2022-04-01
iScience
Abstract:The phenotype of β-thalassemia underlies multigene interactions, making clinical stratification complicated. An increasing number of genetic modifiers affecting the disease severity have been identified, but are still unable to meet the demand of precision diagnosis. Here, we systematically conducted a comparative plasma proteomic profiling on patients with β-thalassemia and healthy controls. Among 246 dysregulated proteins, 13 core protein signatures with excellent biomarker potential are proposed. The combination of proteome and patients' clinical data revealed patients with codons 41/42 -TTCT mutations have an elevated risk of higher iron burden, dysplasia, and osteoporosis than patients with other genotypes. Notably, 85 proteins correlating to fetal hemoglobin (Hb F) were identified, among which the abundance of 27 proteins may affect the transfusion burden in patients with β-thalassemia. The current study thus provides protein signatures as potential diagnostic biomarkers or therapeutic clues for β-thalassemia.
multidisciplinary sciences
What problem does this paper attempt to address?